| BCBS Tennessee Medical Policies | Genetic Testing for Neurodegenerative Disorders | |
| BCBS Tennessee Medical Policies | Laboratory Guideline Policy | |
| BCBS Tennessee Medical Policies | Therapeutic Drug Monitoring for 5-Fluorouracil | |
| BCBS Tennessee Medical Policies | Speech Generating Devices | |
| BCBS Tennessee Medical Policies | Proteogenomic Testing of Individuals With Cancer | |
| BCBS Tennessee Medical Policies | Crizanlizumab-tmca (Adakveo) | |
| BCBS Tennessee Medical Policies | Gene Expression Profiling and Protein Biomarkers for Prostate Cancer | |
| BCBS Tennessee Medical Policies | Esophageal Pathology Testing | |
| BCBS Tennessee Medical Policies | Onychomycosis Testing | |
| BCBS Tennessee Medical Policies | Ambulatory or Video Electroencephalogram (EEG) Monitoring, Including Digital Analysis of Electroencephalogram | |